These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23710562)

  • 21. Do estrogen or selective estrogen receptor modulators improve quality of life for women with postmenopausal osteoporosis?
    Gold DT; Silverman SL
    Curr Osteoporos Rep; 2007 Mar; 5(1):3-7. PubMed ID: 17320021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of severe vertebral fractures with reduced quality of life: reduction in the incidence of severe vertebral fractures by teriparatide.
    Crans GG; Silverman SL; Genant HK; Glass EV; Krege JH
    Arthritis Rheum; 2004 Dec; 50(12):4028-34. PubMed ID: 15593198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
    Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life in Romanian postmenopausal women with osteoporosis and fragility fractures.
    Ciubean AD; Ungur RA; Irsay L; Ciortea VM; Borda IM; Onac I; Vesa SC; Buzoianu AD
    Clin Interv Aging; 2018; 13():2465-2472. PubMed ID: 30584286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteoporosis: a review and its dental implications.
    Mattson JS; Cerutis DR; Parrish LC
    Compend Contin Educ Dent; 2002 Nov; 23(11):1001-4, 1006, 1008 passim; quiz 1014. PubMed ID: 12526189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study.
    Hopman WM; Berger C; Joseph L; Morin SN; Towheed T; Anastassiades T; Adachi JD; Hanley DA; Prior JC; Goltzman D;
    Osteoporos Int; 2019 Aug; 30(8):1635-1644. PubMed ID: 31069440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.
    Blotman F; Cortet B; Hilliquin P; Avouac B; Allaert FA; Pouchain D; Gaudin AF; Cotté FE; El Hasnaoui A
    Drugs Aging; 2007; 24(7):603-14. PubMed ID: 17658910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for osteoporosis related to their outcome: fractures.
    van der Voort DJ; Geusens PP; Dinant GJ
    Osteoporos Int; 2001; 12(8):630-8. PubMed ID: 11580076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between health-related quality of life domains and bone status in postmenopausal Japanese women.
    Tashiro A; Kakuta H; Tanaka N; Takeuchi Y
    Menopause; 2006; 13(5):846-9. PubMed ID: 16894337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and treatment of osteoporosis in women with breast cancer.
    Mincey BA; Moraghan TJ; Perez EA
    Mayo Clin Proc; 2000 Aug; 75(8):821-9. PubMed ID: 10943237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.
    Silverman SL; Delmas PD; Kulkarni PM; Stock JL; Wong M; Plouffe L
    J Am Geriatr Soc; 2004 Sep; 52(9):1543-8. PubMed ID: 15341559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
    Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
    Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in women referred for bone density assessment: relationships with bone mineral density, fracture and co-morbidity.
    Wilson S; Sharp CA; Davie MW
    Qual Life Res; 2015 May; 24(5):1235-43. PubMed ID: 25413779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing and risk factors for clinical fractures among postmenopausal women: a 5-year prospective study.
    van Geel AC; Geusens PP; Nagtzaam IF; Schreurs CM; van der Voort DJ; Rinkens PE; Kester AD; Dinant GJ
    BMC Med; 2006 Oct; 4():24. PubMed ID: 17029622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
    Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
    J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study.
    Silverman SL; Shen W; Minshall ME; Xie S; Moses KH
    J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.